Christopher C. Rowe

62.6k total citations · 9 hit papers
439 papers, 21.6k citations indexed

About

Christopher C. Rowe is a scholar working on Psychiatry and Mental health, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Christopher C. Rowe has authored 439 papers receiving a total of 21.6k indexed citations (citations by other indexed papers that have themselves been cited), including 227 papers in Psychiatry and Mental health, 220 papers in Physiology and 102 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Christopher C. Rowe's work include Dementia and Cognitive Impairment Research (215 papers), Alzheimer's disease research and treatments (210 papers) and Medical Imaging Techniques and Applications (65 papers). Christopher C. Rowe is often cited by papers focused on Dementia and Cognitive Impairment Research (215 papers), Alzheimer's disease research and treatments (210 papers) and Medical Imaging Techniques and Applications (65 papers). Christopher C. Rowe collaborates with scholars based in Australia, United States and United Kingdom. Christopher C. Rowe's co-authors include Victor L. Villemagne, Colin L. Masters, Ralph N. Martins, Olivier Salvado, David Ames, Pierrick Bourgeat, Vincent Doré, Kathryn A. Ellis, Samantha C. Burnham and Paul Maruff and has published in prestigious journals such as Nature, The Lancet and Journal of Neuroscience.

In The Last Decade

Christopher C. Rowe

416 papers receiving 21.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

2013 1.6k citations Victor L. Villemagne, Pierrick Bourgeat et al. profile →
Alzheimer's disease

2015 1.3k citations Colin L. Masters, Christopher C. Rowe et al. profile →
High performance plasma amyloid-β biomarkers for Alzheimer’s disease

2018 1.1k citations Victor L. Villemagne, James D. Doecke et al. profile →
The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

2014 690 citations William E. Klunk, Tammie L.S. Benzinger et al. Alzheimer s & Dementia profile →
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

2011 638 citations Victor L. Villemagne, Kerryn E. Pike et al. Annals of Neurology profile →
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group

2021 598 citations Nicolas Villain, Christopher C. Rowe et al. profile →
Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

2013 402 citations Christopher C. Rowe et al. Alzheimer s & Dementia profile →
Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions

2018 293 citations Victor L. Villemagne, Vincent Doré et al. profile →
Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort

2022 155 citations Pratishtha Chatterjee, Steve Pedrini et al. Alzheimer s & Dementia profile →

Peers

Countries citing papers authored by Christopher C. Rowe

Since Specialization

Citations

This map shows the geographic impact of Christopher C. Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher C. Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher C. Rowe more than expected).

Fields of papers citing papers by Christopher C. Rowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher C. Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher C. Rowe. The network helps show where Christopher C. Rowe may publish in the future.

Co-authorship network of co-authors of Christopher C. Rowe

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher C. Rowe. A scholar is included among the top collaborators of Christopher C. Rowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher C. Rowe. Christopher C. Rowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multivariate models using NULISAseq and plasma p‐tau217 for staging Alzheimer's disease 2025 ·Alzheimer s & Dementia ·James D. Doecke, (unknown), Christopher Fowler, Vincent Doré, Nils Boehm, (unknown), (unknown), Azadeh Feizpour, Larry D. Ward, Jürgen Fripp, Colin L. Masters, Christopher C. Rowe, Anthony W. Bannon	0
2	Baseline habitual dietary nitrate intake and Alzheimer's Disease related neuroimaging biomarkers in the Australian Imaging, Biomarkers and Lifestyle study of ageing 2025 ·The Journal of Prevention of Alzheimer s Disease ·(unknown), Nicola P. Bondonno, Kevin Murray, Liezhou Zhong, Stephanie R. Rainey‐Smith, Samantha L. Gardener, Lauren C. Blekkenhorst, Vincent Doré, Victor L. Villemagne, Simon M. Laws, Belinda M. Brown, Kevin Taddei, Colin L. Masters, Christopher C. Rowe, Ralph N. Martins, Jonathan M. Hodgson, Catherine P. Bondonno	2
3	DeepSUVR: Using temporal constraints to improve SUVR and Centiloid quantification 2024 ·Alzheimer s & Dementia ·Pierrick Bourgeat, Jürgen Fripp, (unknown), Timothy Cox, Manu S. Goyal, Duygu Tosun, Pamela LaMontagne, Tammie L.S. Benzinger, (unknown), Victor L. Villemagne, Colin L. Masters, Christopher C. Rowe, Vincent Doré	0
4	Plasma biomarkers in chronic single moderate–severe traumatic brain injury 2024 ·Brain ·Gershon Spitz, Amelia J. Hicks, Stuart J. McDonald, Vincent Doré, Natasha Krishnadas, Terence J. O’Brien, William T. O’Brien, Lucy Vivash, Meng Law, Jennie Ponsford, Christopher C. Rowe, Sandy R. Shultz	5
5	Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies 2023 ·Journal of Nuclear Medicine ·Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth E. Snitz, Davneet Minhas, Vincent Doré, Miloš D. Ikonomović, C. Elizabeth Shaaban, (unknown), Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. López, Ann D. Cohen, Victor L. Villemagne, (unknown)	8
6	Amyloid‐β and monocytes in Alzheimer’s disease 2023 ·Alzheimer s & Dementia ·Xin Huang, Christopher Fowler, Qiao‐Xin Li, Keyla Perez, Yen Ying Lim, (unknown), Rebecca Rumble, Victor L. Villemagne, Christopher C. Rowe, Ralph N. Martins, Paul Maruff, James D. Doecke, Yong Lin, Kevin J. Barnham, Colin L. Masters, Ben J. Gu	1
7	Longitudinal basal forebrain atrophy in association with amyloid‐β positivity and dementia severity 2023 ·Alzheimer s & Dementia ·Ying Xia, Paul Maruff, Pierrick Bourgeat, Vincent Doré, Victor L. Villemagne, Christopher C. Rowe, Elizabeth J. Coulson, Jürgen Fripp	1
8	Associations of Enlarged Perivascular Spaces With Brain Lesions, Brain Age, and Clinical Outcomes in Chronic Traumatic Brain Injury 2023 ·Neurology ·Amelia J. Hicks, Benjamin Sinclair, Sandy R. Shultz, (unknown), Lisa C. Silbert, Daniel L. Schwartz, Christopher C. Rowe, Jennie Ponsford, Meng Law, Gershon Spitz	23
9	Plasma high‐density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume 2022 ·Journal of Neurochemistry ·Steve Pedrini, James D. Doecke, Eugene Hone, Penghao Wang, Rohith N. Thota, Ashley I. Bush, Christopher C. Rowe, Vincent Doré, Victor L. Villemagne, David Ames, Stephanie R. Rainey‐Smith, Giuseppe Verdile, Hamid R. Sohrabi, Manfred Raida, Kevin Taddei, Sam Gandy, Colin L. Masters, Pratishtha Chatterjee, Ralph N. Martins	13
10	β-Amyloid and Tau Imaging in Chronic Traumatic Brain Injury 2022 ·Neurology ·Amelia J. Hicks, Jennie Ponsford, Gershon Spitz, Vincent Doré, Natasha Krishnadas, (unknown), Christopher C. Rowe	16
11	Human biodistribution and internal dosimetry of 4-[ 18F]fluorobenzyl-dexetimide: a PET radiopharmaceutical for imaging muscarinic acetylcholine receptors in the brain and heart 2020 ·EJNMMI Research ·(unknown), Graeme O’Keefe, Uwe Ackermann, Vincent Doré, Victor L. Villemagne, Christopher C. Rowe	7
12	Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer’s disease 2020 ·Neuroscience Letters ·(unknown), Christopher Fowler, Qiao‐Xin Li, Christopher C. Rowe, Kunal Dhiman, Veer Bala Gupta, Colin L. Masters, James D. Doecke, Ralph N. Martins, Steven Collins, Eleftherios P. Diamandis	5
13	Metabolic patterns and seizure outcomes following anterior temporal lobectomy 2019 ·Annals of Neurology ·(unknown), Benjamin Sinclair, Charles B. Malpas, Anne M. McIntosh, Zhibin Chen, Lucy Vivash, Marie O’Shea, Sarah J. Wilson, Patricia Desmond, Salvatore U. Berlangieri, Rodney J. Hicks, Christopher C. Rowe, Andrew Morokoff, James King, Gavin Fabinyi, Andrew H. Kaye, Patrick Kwan, Samuel F. Berkovic, Terence J. O’Brien	25
14	Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults 2018 ·Archives of Clinical Neuropsychology ·Christa Dang, Karra Harrington, Yen Ying Lim, David Ames, Jason Hassenstab, Simon M. Laws, Nawaf Yassi, Martha Hickey, Stephanie R. Rainey‐Smith, Joanne Robertson, Christopher C. Rowe, Hamid R. Sohrabi, Olivier Salvado, Michael Weinborn, Victor L. Villemagne, Colin L. Masters, Paul Maruff	21
15	Concordance of Text Message Ecological Momentary Assessment and Retrospective Survey Data Among Substance-Using Men Who Have Sex With Men: A Secondary Analysis of a Randomized Controlled Trial 2016 ·JMIR mhealth and uhealth ·Christopher C. Rowe, Jaclyn Hern, (unknown), D. B. Jennings, (unknown), John E. Walker, Glenn‐Milo Santos	24
16	Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study 2012 ·Brain ·Nicolas Villain, Gaël Chételat, Blandine Grassiot, Pierrick Bourgeat, Gareth Jones, Kathryn A. Ellis, David Ames, Ralph N. Martins, Francis Eustache, Olivier Salvado, Colin L. Masters, Christopher C. Rowe, Victor L. Villemagne	195
17	Blood-Borne Amyloid-β Dimer Correlates with Clinical Markers of Alzheimer's Disease 2010 ·Journal of Neuroscience ·Victor L. Villemagne, Keyla Perez, Kerryn E. Pike, W. Mei Kok, Christopher C. Rowe, Anthony R. White, Pierrick Bourgeat, Olivier Salvado, Justin Bedő, Craig A. Hutton, Noel G. Faux, Colin L. Masters, Kevin J. Barnham	62
18	Characterization of PiB Binding to White Matter in Alzheimer Disease and Other Dementias 2009 ·Journal of Nuclear Medicine ·Michelle T. Fodero‐Tavoletti, Christopher C. Rowe, Catriona McLean, Laura Leone, Qiao‐Xin Li, Colin L. Masters, Roberto Cappai, Victor L. Villemagne	79
19	In VitroCharacterization of Pittsburgh Compound-B Binding to Lewy Bodies 2007 ·Journal of Neuroscience ·Michelle T. Fodero‐Tavoletti, David P. Smith, Catriona McLean, Paul A. Adlard, Kevin J. Barnham, (unknown), Laura Leone, Keyla Perez, Mikhalina Cortés, Janetta G. Culvenor, Qiao‐Xin Li, Katrina Laughton, Christopher C. Rowe, Colin L. Masters, Roberto Cappai, Victor L. Villemagne	128
20	Éthique et métaphysique platoniciennes ou pourquoi il faut abandonner la classification en dialogues de jeunesse, de maturité et de vieillesse 2004 ·Industrias Culturais (Universidade de Coimbra) ·Christopher C. Rowe	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact